RxDoctor Payments Data

Andrew Campbell

Primary Podiatric Medicine · Altamonte Springs, FLNPI 1659431583

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 69 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $606 and has fallen 95.4% since, to $28 in 2025.

$2,576in general payments, 2019–2025

Across 69 payments — averaging $37.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$470
  • Organogenesis Inc.$340
  • Amgen$255
  • Bioventus LLC$217
  • Medtronic$161
  • AbbVie$157
  • plus $977 from 14 others

What the payments were for

  • Food & beverage$2,576100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,576 in reported general payments places this provider in the 75th percentile of 68 primary podiatric medicine providers in Florida.

See all primary podiatric medicine providers in Florida

Medicare billing

Part B allowed, 2024
$18,531
Medicare patients
77
Services billed
282

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clotrimazole77$1,931
Fluocinonide13$1,585
Diclofenac Sodium ErDiclofenac Sodium16$1,166
Ammonium Lactate65$927
Ketoconazole18$901
Diclofenac Sodium12$321

Paid to pharmacies, not to this prescriber.

Other primary podiatric medicine in Altamonte Springs

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →